Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Journal of Visualized Experiments : Jove|February 5, 2015
Production and use of lentivirus to selectively transduce primary oligodendrocyte precursor cells for in vitro myelination assaysHaley M Peckham, Anita H Ferner, Lauren Giuffrida, et al.Glia|October 10, 2015
Fyn is an intermediate kinase that BDNF utilizes to promote oligodendrocyte myelinationHaley Peckham, Lauren Giuffrida, Rhiannon Wood, et al.Journal of Neuropathology and Experimental Neurology|January 14, 2017
A Functional and Neuropathological Testing Paradigm Reveals New Disability-Based Parameters and Histological Features for P0180-190-Induced Experimental Autoimmune Neuritis in C57BL/6 MiceDavid G Gonsalvez, Mithraka De Silva, Rhiannon J Wood, et al.Molecular and Cellular Neurosciences|December 3, 2014
TDP6, a brain-derived neurotrophic factor-based trkB peptide mimetic, promotes oligodendrocyte myelinationAgnes W Wong, Lauren Giuffrida, Rhiannon Wood, et al.Therapeutic Advances in Vaccines and Immunotherapy|June 23, 2021
Generating CAR T cells from tumor-infiltrating lymphocytesJane K Mills, Melissa A Henderson, Lauren Giuffrida, et al.Cancer Research|January 14, 2017
A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T CellsSherly Mardiana, Liza B John, Melissa A Henderson, et al.Cancer Immunology Research|July 19, 2018
Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3- Cell-Mediated Modulation of CD103+ Dendritic CellsPaul A Beavis, Melissa A Henderson, Lauren Giuffrida, et al.The Journal of Clinical Investigation|February 7, 2017
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacyPaul A Beavis, Melissa A Henderson, Lauren Giuffrida, et al.Plos Genetics|March 19, 2016
Common and Low Frequency Variants in MERTK Are Independently Associated with Multiple Sclerosis Susceptibility with Discordant Association Dependent upon HLA-DRB1*15:01 StatusMichele D Binder, Andrew D Fox, Daniel Merlo, et al.Nature Communications|May 29, 2021
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacyLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.Pageof 2